Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi
Open Access
- 29 September 2020
- journal article
- research article
- Published by Springer Nature in BMC Research Notes
- Vol. 13 (1) , 1-7
Abstract
Objective: Lyme disease is a tick-borne, multisystemic disease caused by Borrelia burgdorferi. Standard treatments for early Lyme disease include short courses of oral antibiotics but relapses often occur after discontinuation of treatment. Several studies have suggested that ongoing symptoms may be due to a highly antibiotic resistant form of B. burgdorferi called biofilms. Our recent clinical study reported the successful use of an intracellular mycobacterium persister drug used in treating leprosy, diaminodiphenyl sulfone (dapsone), in combination therapy for the treatment of Lyme disease. In this in vitro study, we evaluated the effectiveness of dapsone individually and in combination with cefuroxime and/or other antibiotics with intracellular activity including doxycycline, rifampin, and azithromycin against Borrelia biofilm forms utilizing crystal violet biofilm mass, and dimethyl methylene blue glycosaminoglycan assays combined with Live/Dead fluorescent microscopy analyses. Results: Dapsone, alone or in various combinations with doxycycline, rifampin and azithromycin produced a significant reduction in the mass and protective glycosaminoglycan layer and overall viability of B. burgdorferi biofilm forms. This in vitro study strongly suggests that dapsone combination therapy could represent a novel and effective treatment option against the biofilm form of B. burgdorferi.Keywords
All Related Versions
Funding Information
- Global Lyme Alliance (not known)
This publication has 37 references indexed in Scilit:
- Characterization of Biofilm Formation by Borrelia burgdorferi In VitroPLOS ONE, 2012
- Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferiInfection and Drug Resistance, 2011
- Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosisJournal of Neuroinflammation, 2008
- A new colorimetric microtitre model for the detection of Staphylococcus aureus biofilmsLetters in Applied Microbiology, 2007
- Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritisClinics in Dermatology, 2006
- Spirochetal cyst forms in neurodegenerative disorders,…hiding in plain sightMedical Hypotheses, 2006
- Azithromycin Exhibits Bactericidal Effects on Pseudomonas aeruginosa through Interaction with the Outer MembraneAntimicrobial Agents and Chemotherapy, 2005
- Invasion of Human Skin Fibroblasts by the Lyme Disease Spirochete, Borrelia burgdorferiThe Journal of Infectious Diseases, 1993
- Recurrent erythema migrans despite extended antibiotic treatment with minocycline in a patient with persisting Borrelia burgdorferi infectionJournal of the American Academy of Dermatology, 1993
- Clinical Pharmacokinetics of DapsoneClinical Pharmacokinetics, 1986